These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

666 related items for PubMed ID: 9694935

  • 21. Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization.
    Caballero R, Delpón E, Valenzuela C, Longobardo M, González T, Tamargo J.
    Mol Pharmacol; 2001 Apr; 59(4):825-36. PubMed ID: 11259627
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of HERG K+ current and prolongation of the guinea-pig ventricular action potential by 4-aminopyridine.
    Ridley JM, Milnes JT, Zhang YH, Witchel HJ, Hancox JC.
    J Physiol; 2003 Jun 15; 549(Pt 3):667-72. PubMed ID: 12740430
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.
    Paul AA, Witchel HJ, Hancox JC.
    Br J Pharmacol; 2002 Jul 15; 136(5):717-29. PubMed ID: 12086981
    [Abstract] [Full Text] [Related]

  • 24. Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241.
    Suessbrich H, Schönherr R, Heinemann SH, Lang F, Busch AE.
    FEBS Lett; 1997 Sep 08; 414(2):435-8. PubMed ID: 9315735
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action.
    Thomas D, Hammerling BC, Wu K, Wimmer AB, Ficker EK, Kirsch GE, Kochan MC, Wible BA, Scholz EP, Zitron E, Kathöfer S, Kreye VA, Katus HA, Schoels W, Karle CA, Kiehn J.
    Br J Pharmacol; 2004 Jun 08; 142(3):485-94. PubMed ID: 15148258
    [Abstract] [Full Text] [Related]

  • 26. Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels.
    Caballero R, Moreno I, González T, Arias C, Valenzuela C, Delpón E, Tamargo J.
    Circulation; 2003 Feb 18; 107(6):889-95. PubMed ID: 12591761
    [Abstract] [Full Text] [Related]

  • 27. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
    Po SS, Wang DW, Yang IC, Johnson JP, Nie L, Bennett PB.
    J Cardiovasc Pharmacol; 1999 Feb 18; 33(2):181-5. PubMed ID: 10028924
    [Abstract] [Full Text] [Related]

  • 28. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
    Busch AE, Eigenberger B, Jurkiewicz NK, Salata JJ, Pica A, Suessbrich H, Lang F.
    Br J Pharmacol; 1998 Jan 18; 123(1):23-30. PubMed ID: 9484850
    [Abstract] [Full Text] [Related]

  • 29. Effects of bupivacaine and a novel local anesthetic, IQB-9302, on human cardiac K+ channels.
    González T, Longobardo M, Caballero R, Delpón E, Tamargo J, Valenzuela C.
    J Pharmacol Exp Ther; 2001 Feb 18; 296(2):573-83. PubMed ID: 11160646
    [Abstract] [Full Text] [Related]

  • 30. Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide.
    Ridley JM, Milnes JT, Benest AV, Masters JD, Witchel HJ, Hancox JC.
    Biochem Biophys Res Commun; 2003 Jun 27; 306(2):388-93. PubMed ID: 12804575
    [Abstract] [Full Text] [Related]

  • 31. The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels.
    Thomas D, Gut B, Wendt-Nordahl G, Kiehn J.
    J Pharmacol Exp Ther; 2002 Feb 27; 300(2):543-8. PubMed ID: 11805215
    [Abstract] [Full Text] [Related]

  • 32. Use-dependent 'agonist' effect of azimilide on the HERG channel.
    Jiang M, Dun W, Fan JS, Tseng GN.
    J Pharmacol Exp Ther; 1999 Dec 27; 291(3):1324-36. PubMed ID: 10565858
    [Abstract] [Full Text] [Related]

  • 33. QT interval prolongation and cardiac risk assessment for novel drugs.
    Picard S, Lacroix P.
    Curr Opin Investig Drugs; 2003 Mar 27; 4(3):303-8. PubMed ID: 12735231
    [Abstract] [Full Text] [Related]

  • 34. Block of HERG-carried K+ currents by the new repolarization delaying agent H 345/52.
    Amos GJ, Jacobson I, Duker G, Carlsson L.
    J Cardiovasc Electrophysiol; 2003 Jun 27; 14(6):651-8. PubMed ID: 12875428
    [Abstract] [Full Text] [Related]

  • 35. Effects of Na+ channel blocker, pilsicainide, on HERG current expressed in HEK-293 cells.
    Wu LM, Orikabe M, Hirano Y, Kawano S, Hiraoka M.
    J Cardiovasc Pharmacol; 2003 Sep 27; 42(3):410-8. PubMed ID: 12960687
    [Abstract] [Full Text] [Related]

  • 36. Modulation of rat erg1, erg2, erg3 and HERG K+ currents by thyrotropin-releasing hormone in anterior pituitary cells via the native signal cascade.
    Schledermann W, Wulfsen I, Schwarz JR, Bauer CK.
    J Physiol; 2001 Apr 01; 532(Pt 1):143-63. PubMed ID: 11283231
    [Abstract] [Full Text] [Related]

  • 37. Open channel block of HERG K(+) channels by vesnarinone.
    Kamiya K, Mitcheson JS, Yasui K, Kodama I, Sanguinetti MC.
    Mol Pharmacol; 2001 Aug 01; 60(2):244-53. PubMed ID: 11455010
    [Abstract] [Full Text] [Related]

  • 38. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.
    Zhou Z, Gong Q, Ye B, Fan Z, Makielski JC, Robertson GA, January CT.
    Biophys J; 1998 Jan 01; 74(1):230-41. PubMed ID: 9449325
    [Abstract] [Full Text] [Related]

  • 39. The antipsychotic drug chlorpromazine inhibits HERG potassium channels.
    Thomas D, Wu K, Kathöfer S, Katus HA, Schoels W, Kiehn J, Karle CA.
    Br J Pharmacol; 2003 Jun 01; 139(3):567-74. PubMed ID: 12788816
    [Abstract] [Full Text] [Related]

  • 40. Blockade of HERG channels expressed in Xenopus oocytes by external H+.
    Jo SH, Youm JB, Kim I, Lee CO, Earm YE, Ho WK.
    Pflugers Arch; 1999 Jun 01; 438(1):23-9. PubMed ID: 10370083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.